SCHEMBL4007790

SCHEMBL4007790

CCCCC(C)C(C)C(CNC(=O)C(N)CC(C)C)CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 2/20 0.40
SLC15A1 P46059 1/20 0.38
GPR88 Q9GZN0 1/20 0.36
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
RRM1 P23921 1/20 0.35
SLC7A5 Q01650 1/20 0.35
EPHX1 P07099 1/20 0.35
ANPEP P15144 3/20 0.34
RNPEP Q9H4A4 2/20 0.34
DNPEP Q9ULA0 2/20 0.34
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4010230 1.00 DPP7 (0.40) DPP7SLC15A1GPR88SLC1A3SLC1A2
SCHEMBL4014258 1.00 DPP7 (0.40) DPP7SLC15A1GPR88SLC1A3SLC1A2
SCHEMBL4009431 0.92 GPR88 (0.39) DPP7GPR88SLC1A3SLC1A2SLC1A1
SCHEMBL4009833 0.92 GPR88 (0.39) DPP7GPR88SLC1A3SLC1A2SLC1A1
SCHEMBL4009839 0.92 GPR88 (0.39) DPP7GPR88SLC1A3SLC1A2SLC1A1
SCHEMBL4005119 0.87 SLC7A5 (0.39) GPR88SLC1A3SLC1A2SLC7A5ANPEP
SCHEMBL4014134 0.87 SLC15A1 (0.44) DPP7SLC15A1GPR88SLC1A3SLC1A2
SCHEMBL4017745 0.87 SLC15A1 (0.44) DPP7SLC15A1GPR88SLC1A3SLC1A2
SCHEMBL4007846 0.87 SLC7A5 (0.39) GPR88SLC1A3SLC1A2SLC7A5ANPEP
SCHEMBL4011304 0.87 SLC7A5 (0.39) GPR88SLC1A3SLC1A2SLC7A5ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491835-B2 Prodrugs of amino acids with affinity for the α2δ-protein PFIZER INC (US) 2009-02-17 US claimed
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein VIATRIS SPECIALTY LLC. 2005-03-31 US claimed
US-7491835-B2 Prodrugs of amino acids with affinity for the α2δ-protein PFIZER INC (US) 2009-02-17 US disclosed
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein VIATRIS SPECIALTY LLC. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A DPP7 1105/4885SLC15A1 745/4885GPR88 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.